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Abstract
Background: The quality of life in patients with diabetes is reduced and emotional coping with the disease has great 
impact on patient well-being.
Objectives: The aim of this study was to assess the psychological well-being and treatment satisfaction in patients 
with type 2 diabetes mellitus in primary care.
Study Design and Setting: Patients (n = 112) with type 2 diabetes mellitus diagnosis for at least six months were 
enrolled. The Well-Being Questionnaire-22 and the Diabetes Treatment Satisfaction Questionnaire were used. Physical 
examination and laboratory investigations were performed.
Results: The rates of the achieved targets were 32.1% for hemoglobin A1c, 62.5% for cholesterol and 20.5% for blood 
pressure. The mean scores for the general well-being, depression, anxiety, positive well-being and energy were 44.40 ± 
13.23 (range = 16-62), 12.65 ± 3.80 (range = 5-18), 10.57 ± 4.47 (range = 1-18), 12.00 ± 4.01 (range = 2-18), and 9.16 ± 
2.47 (range = 2-12), respectively. The mean scores for the treatment satisfaction, perception for hyperglycemia and 
perception for hypoglycemia were 22.37 ± 9.53 (range = 0.00-36.00), 1.71 ± 1.59 (range = 0-6), and 0.51 ± 0.98 (range = 
0-6), respectively. There were significant associations between the depression score and the educational status, 
compliance to diet and physical exercise, and diabetic complications; between the anxiety score and the educational 
status, glycemic control, compliance to diet and physical exercise; between the energy score and the educational 
status, compliance to physical exercise, and diabetic complications; between the positive well-being score and the 
educational status, compliance to diet and physical exercise, complications and type of treatment; between the 
general well-being score and the educational status, compliance for diet and physical exercise, and complications. 
Treatment satisfaction was significantly associated to the educational status, glycemic control and compliance to diet 
and physical exercise. A significant correlation was found between the treatment satisfaction and the well-being.
Conclusions: Individualized care of patients with diabetes should consider improving the quality of life. Psychosocial 
support should be provided to the patients with type 2 diabetes and the negative effects of psychopathological 
conditions on the metabolic control should be lessened.
Background
Diabetes is a chronic illness that requires continuing
medical care and patient self-management education to
prevent acute complications and to reduce the risk of
long-term complications. Diabetes currently affects 246
million people worldwide and is expected to affect 380
million by 2025. The estimated prevalence of diabetes in
the United States is 7.8% overall and 10.7% in the popula-
tion over age 20 [1]. In 2002, visits to primary care physi-
cians accounted for 62.7% of all office visits in the United
States, and diabetes mellitus ranked third, accounting for
3.1% of illness-related diagnoses [2]. Diabetes is a fre-
quent disease also in Turkey with a prevalence of 7.2% [3].
T h e  q u a l i t y  o f  l i f e  ( Q o L )  i n  p a t i e n t s  w i t h  d i a b e t e s  i s
reduced and it was well-shown that emotional coping
with the diagnosis, daily treatment need and acute and
chronic complications had great impact of the physical,
psychological and social well-being of the patient with
diabetes. * Correspondence: esaatci@cu.edu.tr
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The aim of this study was to assess the level of psycho-
logical well-being and treatment satisfaction in patients
with type 2 diabetes mellitus followed in primary care.
Methods
Sample
All patients (n = 112) with type 2 diabetes mellitus who
admitted to Family Medicine Outpatient Clinic of Cuku-
rova University Faculty of Medicine Department of Fam-
ily Medicine from March 2007 to September 2007 were
enrolled in this study. Inclusion criterion was to have
d i a g n o s i s  o f  t y p e  2  d i a b e t e s  m e l l i t u s  f o r  a t  l e a s t  s i x
months.
Procedure and Data Collection
Three questionnaires were self-completed by the
patients: sociodemographic (including questions on age,
gender, educational status, body weight, height, duration
of diabetes, acute and chronic complications, medica-
tions used, patient education on diabetes, other chronic
conditions such as hypertension, hyperlipidemia, athero-
sclerotic heart disease, obesity etc, medications for the
chronic conditions other than diabetes mellitus, compli-
ance to diet and physical exercise, findings of the physical
examination and laboratory investigations), Well-Being
Questionnaire-22 (WBQ-22) and Diabetes Treatment
Satisfaction Questionnaire (DTSQ). After physical exam-
ination including blood pressure measurement; ECG,
blood laboratory tests (fasting blood glucose, postpran-
dial blood glucose, glycosylated hemoglobin (HbA1C),
total cholesterol, high density lipoprotein-cholesterol
(HDL-C), low density lipoprotein-cholesterol (LDL-C),
triglycerid, urea, and creatinine) and microalbuminuria
in the spot urine were performed for all patients in the
study.
Questionnaires
WHO-Well-Being Questionnaire (WBQ-22)
The 22-item Well-Being Questionnaire (WBQ-22) [4-6]
was originally designed in 1982 [7]. It was developed to
provide a measure of mood, anxiety, and aspects of posi-
tive well-being for use in a WHO study evaluating new
treatments for diabetes [8]. The instrument was initially
developed with type 1 diabetes mellitus patients but has
also been developed with type 2 diabetes mellitus
patients. The items were derived from the psychological
general well-being scale. It was designed to assess the
patient's perception of general well-being and measures a
component of quality of life known to be particularly rel-
evant to patients with diabetes. The instrument was
designed to assess the efficacy of new measures. The
inclusion of a positive well-being dimension was designed
to increase the sensitivity of the instrument. The positive
well-being dimension was designed to assess psychologi-
cal aspects of well-being, both negative and positive. Var-
ious versions of the questionnaire are already used in
several diabetes programs across the world. The original
instrument consisted of 28 items. The version used in this
study, the WHO-WBQ [9], consists of 22 items with a
Cronbach alpha value of 0.87 [10]. The WHO-WBQ-(22
item) is also used to construct a profile consisting of four
subscales of depression, anxiety, energy, and positive
well-being. Each item is scored on a 0 to 3 Likert-type
scale, where "0" represents not at all and "3" represents all
the time. The theoretical combined score range, there-
fore, extends from 0 (worst possible) to 66 (best possible).
Ratings for the items are summed, after reversal where
necessary. A higher score indicates more of the specific
mood state. Savli and Sevinc [11] carried out the validity
and reliability assessments of the scale in Turkey [12].
The Diabetes Treatment Satisfaction Questionnaire (DTSQ)
The Diabetes Treatment Satisfaction Questionnaire
(DTSQ) was developed to assess the total diabetes treat-
ment satisfaction and can be used in patients with type 1
or type 2 diabetes mellitus. It consists of eight items each
rated on a seven-point Likert Scale. Six (items 1, 4-8) of
them (item 1: satisfaction with current treatment; item 4:
treatment convenience; item 5: flexibility of treatment;
item 6: understanding of diabetes; item 7: continuity of
treatment, and item 8: recommending treatment to oth-
ers with diabetes), are summed to get treatment satisfac-
tion score with a possible range of 0 (very dissatisfied) to
36 (very satisfied). Item 2 evaluates perceived frequency
of hyperglycemia and item 3 perceived frequency of
hypoglycemia and they are also rated on a seven point
scale (0-6) same as other items but for these two items a
score of zero indicates a lack of hyperglycemia or hypo-
glycemia while a higher score indicates a higher fre-
quency. These two benchmark items were used for
criterion validity testing [13].
Ethics and Informed Consent
The study was approved by the Ethics Committee of
Cukurova University Faculty of Medicine. Written
informed consent was obtained from each patient in the
study.
Data Analysis
Data was installed and analyzed using SPSS for Windows
15.0 statistical pocket program. Mann-Whitney U,
Kruskal Wallis, Pearson Chi-Square and Spearman's non-
parametric correlation tests were used. We used Bonfer-
roni test for multivariable comparisons. The level of sig-
nificance was set as p < 0.05.
Results
Patient Demographics
Of patients 37 (33%) were male and 75 (67%) were female
(Table 1). The mean age for males was 59.89 ± 10.40 years
and the mean age for females was 55.60 ± 9.17 yearsSaatci et al. Health and Quality of Life Outcomes 2010, 8:67
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(range = 35-85 years). Almost half of the patients were
primary school graduates.
Health indicators
The rates of achievement for the target levels of HbA1c
(HbA1c < %7), cholesterol (<200 mg/dl), LDL-C (<100
mg/dl), triglyceride (<150 mg/dl), not having albuminu-
ria, and blood pressure (<130/80 mmHg) were 32.1%,
62.5%, 32.1%, 33.0%, 83.3%, and 20.5%. There was no sig-
nificant association between the blood test results (fast-
ing and postprandial blood glucose, and lipid panel) and
WBQ-22 scores of the patients (p > 0.05). Of our patients,
37.5% (n = 42) were obese and 38.4% (n = 43) were over-
weight. There was no significant relationship between
p a t i e n t s '  c o m p l i a n c e  t o  d i e t  a n d  p h y s i c a l  e x e r c i s e  a n d
body mass index (BMI) (p > 0.05 for both).
WBQ-22 scale results
The mean scores for the general well-being, depression,
anxiety, positive well-being and energy were 44.40 ±
13.23 (range = 16-62), 12.65 ± 3.80 (range = 5-18), 10.57 ±
4.47 (range = 1-18), 12.00 ± 4.01 (range = 2-18), and 9.16
± 2.47 (range = 2-12), respectively. There was no signifi-
cant association between gender and well-being scores (p
> 0.05). Subscale scores of well-being showed improve-
ment as the educational status of patient improved (Table
2).
There was a significant association between depression
scores of patients who were illiterate and who were not (p
= 0.0006) and between those who had basic skills of read-
ing-writing and who were graduated from primary or
high school (p = 0.0006). Anxiety scores of patients were
also significantly different for these educational groups (p
= 0.006 for illiterate patients and high school graduates; p
= 0.036 for patients with basic skills of reading-writing
and high school graduates). It was also true for the energy
subscore (p = 0.018 for illiterate patients and high school
graduates; p = 0.012 for patients with basic skills of read-
ing-writing and primary school graduates; p = 0.0006 for
patients with basic skills of reading-writing and high
school graduates). It was similar for the positive well-
being and general well-being subscores.
There was no significant association between the
patients' body mass index and WBQ-22 subscores (p >
0.05). However, patients with better compliance for diet
had better scores for depression, anxiety, positive well-
being, and general well-being (p = 0.008, p = 0.014, p =
0.001, p = 0.002, respectively) and patients with better
compliance for regular physical exercise had higher
scores for all subscores (p = 0.0001 for each). Improve-
Table 1: Description of patient population (n = 112)
Male
n (%)
Female
n (%)
Total
n (%)
Age groups (years) ≤49 6 (16.2) 18 (24.0) 24 (21.4)
50-54 5 (13.5) 20 (26.7) 25 (22.3)
55-59 6 (16.2) 13 (17.3) 19 (17.0)
60-64 6 (16.2) 13 (17.3) 19 (17.0)
≥65 14 (37.8) 11 (14.7) 25 (22.3)
Total 37 (33.0) 75 (67.0) 112 (100)
Education status Illiterate 1 (2.8) 20 (27.4) 21 (19.3)
Basic skills for reading-writing 5 (13.9) 13 (17.8) 18 (16.5)
Primary school graduate 16 (44.4) 32 (43.8) 48 (44.0)
High school 14 (38.9) 8 (11.0) 22 (20.2)
Total 36 (33.0) 73 (67.0) 109 (100)Saatci et al. Health and Quality of Life Outcomes 2010, 8:67
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ment in HbA1c levels were associated with less anxiety (p
= 0.046). There was no significant association between
the duration of diabetes and well-being scores (p > 0.05
for each). Patients' well-being was significantly associated
with the presence or absence of diabetic complications
(Table 3). Patients without any diabetic complications
had better scores for depression, positive well-being,
energy and general well-being (except for anxiety score)
(p = 0.003, p = 0.003, p = 0.040, p = 0.018, respectively).
The type of oral hypoglycemic agents (OHA) was signifi-
c a n t l y  a s s o c i a t e d  w i t h  p o s i t i v e  w e l l - b e i n g  s c o r e  ( p  =
0.024).
DTSQ scale results
Seven patients who had diabetes diagnosis for more than
o ne  yea r di d not  c om plet e  t his  sca le  as  t h ey  we r e  no t
using any medications due to various reasons. The mean
scores for the treatment satisfaction, perception for
hyperglycemia and perception for hypoglycemia were
22.37 ± 9.53 (range = 0.00-36.00), 1.71 ± 1.59 (range = 0-
6), and 0.51 ± 0.98 (range = 0-6), respectively. There was
no significant association between DTSQ mean total
scores and patients' age, gender, BMI, the duration of dia-
betes, and the type of treatment (p > 0.05). DTSQ total
scores showed a significant association with the patients'
educational status (p = 0.0001) (Table 4). Patients with
lower HbAıc levels had higher treatment satisfaction (p =
0.001) and patients with complications had lower treat-
ment satisfaction (p = 0.0001).
There was no significant association between DTSQ
total scores, DTSQ-2 or DTSQ-3 and compliance to diet
and exercise (p > 0.05, for each). There was no significant
association between DTSQ-2 and DTSQ-3 scores and the
type of treatment (p > 0.05, for both).
Comparing DTSQ and WBQ-22
There was a significant correlation between DTSQ total
scores and WBQ-22 subscale scores (p = 0.0001 for each
subscale score) (Table 5). There was significant correla-
Table 2: The Subscale Scores of WBQ-22 and Educational Status of Patients in the Study (n = 109)
Mean ± SD Educational status
Illiterate n = 21 Basic reading-writing 
skills n = 18
Primary school 
n = 48
High school n = 22 Total n = 109 p
Depression 10.14 ± 3.1 10.11 ± 3.5 13.62 ± 3.2 15.63 ± 2.1 12.77 ± 3.7 0.0001
Anxiety 7.90 ± 4.5 9.55 ± 4.5 11.43 ± 4.5 12.45 ± 2.5 10.65 ± 4.4 0.004
Positive well-being 9.33 ± 3.4 10.00 ± 3.2 12.85 ± 3.9 14.90 ± 2.3 12.11 ± 3.9 0.0001
Energy 7.90 ± 2.8 7.94 ± 1.7 9.68 ± 2.3 10.45 ± 1.6 9.21 ± 2.4 0.0001
General well-being 35.28 ± 12.3 37.61 ± 11.9 47.60 ± 12.3 53.45 ± 7.0 44.76 ± 13.1 0.0001
Table 3: The Subscale Scores of WBQ-22 and Diabetic Complications (n = 112)
Mean ± SD Diabetic complications
Yes (n = 30) No (n = 82) Total (n = 112) p
Depression 10.73 ± 4.0 13.35 ± 3.4 12.65 ± 3.8 0.003
Anxiety 9.66 ± 4.8 10.90 ± 4.3 10.57 ± 4.4 0.189
Positive well-being 10.03 ± 4.3 12.73 ± 3.6 12.00 ± 4.01 0.003
Energy 8.36 ± 2.6 9.46 ± 2.3 9.16 ± 2.4 0.040
General well-being 38.80 ± 14.7 46.45 ± 12.1 44.40 ± 13.2 0.018Saatci et al. Health and Quality of Life Outcomes 2010, 8:67
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tion between DTSQ-2 and depression, anxiety, positive
well-being, energy and general well-being scores (p =
0.002, p = 0.025, p = 0.005, p = 0.027, p = 0.004, respec-
tively) (Table 6). There was significant correlation
between DTSQ-3 and depression, energy and general
well-being scores (p = 0.029, p = 0.036, p = 0.030, respec-
tively) (Table 6).
Discussion
A l t h o u g h  i t  w a s  r e po r t ed  t h a t  g e n d e r  i n fl u e n c e d  w e l l -
being we could not find a significant association between
gender and well-being [14-16]. This inconsistency may be
due to the low number of patients in our study.
Although a number of authors [15,17] could not con-
firm the correlation between HbA1c and quality of life, a
positive association has been reported in some cross-sec-
tional surveys [18,19]. Savli et al found that there was a
correlation between fasting and post-prandial blood glu-
cose levels and anxiety score i.e. patients with diabetes
worry with elevated blood glucose levels [11]. Van
Tilburg et al revealed a significant positive relationship
between depression and HbA1c in the type 1 group but
not in the type 2 group [20]. On the contrary, Lustman et
al showed in the meta-analytic review of the literature
that depression was associated with hyperglycemia in
patients with type 1 or type 2 diabetes [21]. We found a
significant association only between HbA1c  levels and
anxiety scores. The poor association between metabolic
control and well-being may be due to the fact that HbA1c
represents the last four months where WBQ-22 the last
1-2 weeks.
In a study from primary care, mean HbA1c level was
7.6% and 40.5% of patients had values <7% [2]. Only
35.3% of patients were at or below target blood pressure
(<130/85 mmHg) recommended by the American Diabe-
tes Association (ADA) with only 74% below the Joint
National Committee 7 (JNC 7) level for stage 1 hyperten-
sion (140/90 mmHg), only 43.7% had low-density lipo-
protein cholesterol levels <100 mg/dL, and only 7.0% of
patients met all three control targets [2]. These results are
similar to those of NHANES 3 study (HbA1c level <7% in
42.3% of patients, mean value 7.8%) [22] whereas they are
better than those reported in a recent retrospective study
of general medicine and endocrinology clinics in aca-
demic medical centers from 2000-2002 (HbA1c <7% in
34% of patients, mean value 7.9%-8.1%) [23]. It was
reported that only 37% of adult patients with diabetes
achieved the goal of HbA1c level <7%, only 36% had blood
pressure <130/80 mmHg, and only 48% had cholesterol
level <200 mg/dl. Worse, only 7.3% of patients with diabe-
tes could achieve these three targets [23]. In our study,
32.1% of patients achieved target levels of HbA1c
(HbA1c<%7) and there was a significant association
between HbA1c levels and anxiety score. The patients had
less anxiety if their blood glucose control status was bet-
ter. Our patients' cholesterol control was better than gly-
cemic control with 62.5% of patients with total
cholesterol level <200 mg/dl.
Among patients with diabetes, the benefits of regular
physical activity have been well documented [24]. It was
shown that restrictions on dietary freedom have a major
negative impact on QoL [25]. We found a significant
association between the compliance to diet and well-
being subscale scores (except for the energy subscore).
We also found significant association between regular
physical exercise and all subscale scores of well-being.
This can be related to better compliance for the disease or
to being a good self-manager of this chronic condition.
Patient's being able to achieve the recommended life style
changes may contribute to the well-being of the diabetic
patient.
Table 4: The total DTSQ Scores and Educational Status of Patients in the Study (n = 105)
Mean ± SD Educational status
Illiterate n = 21 Basic reading-writing 
skills n = 16
Primary school n = 46 High school n = 22 Total n = 105 p
DTSQ total 18.09 ± 9.0 17.31 ± 8.8 24.65 ± 8.6 26.72 ± 8.9 22.65 ± 9.4 0.0001
Table 5: The Correlation between Subscale Scores of WBQ-
22 and DTSQ Total Score (n = 105)
WBQ-22 subscales DTSQ total score
Correlation coefficient p
Depression 0.557 0.0001
Anxiety 0.464 0.0001
Positive well-being 0.503 0.0001
Energy 0.387 0.0001
General well-being 0.551 0.0001Saatci et al. Health and Quality of Life Outcomes 2010, 8:67
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Harris found that hypertension is an important risk fac-
tor for cardiovascular disease, nephropathy and retinopa-
thy and clinical hypertension was present in 63% of
patients [22]. Only 50.1% of patients with type 2 diabetes
in NHANES III sample had blood pressures below 140/90
mmHg [22]. In our study, only 20.5% of our patients had
adequate blood pressure control (<130/80 mmHg). This
finding is consistent with the fact that despite significant
Joint National Committee (JNC) efforts, a majority of
patients are not reaching their blood pressure goals. A
2003 study conducted in eight managed care organiza-
tions in the United States concluded that less than 50% of
plan members diagnosed with hypertension met their
blood pressure goal (JNC 6). This conclusion held even
after various educational and awareness campaigns were
initiated [26]. In addition, data from the National Health
and Nutrition Examination Survey (NHANES) revealed
that only 36.8% of patients (including those undiagnosed)
were at their target blood pressure [27].
The Third Report of the National Cholesterol Educa-
tion Program (NCEP) Expert Panel on Detection, Evalua-
tion and Treatment of High Blood Cholesterol in Adults
(Adult Treatment Panel III) considers patients with dia-
b e t e s  t o  b e  a t  h i g h  r i s k  o f  c a r d i o v a s c u l a r  e v e n t s  a n d
therefore recommends the same LDL-C goal as those for
patients with established cardiovascular disease (CVD)
(LDL-C < 100 mg/dl) [28]. In our study, 32.1% of patients
achieved LDL-C target levels of 100 mg/dL compared
with 15.4% of patients in the NHANES III study [22], 45%
of patients in the Vermont Diabetes Information System
Trial [29], and 43.7% of patients in the study by Spann et
al [2].
Patients treated with insulin had higher depression and
lower general well-being scores than patients treated with
oral antidiabetic agents and diet [11]. We found a signifi-
cant association between OHA and positive well-being.
However, this finding should not be generalized as the
number of patients administering insulin therapy was
very few in our study.
Patients with a diabetes period of less than five years
had lower depression scores compared to patients with a
disease period of more than five years [11]. On the other
hand, patients with a disease period of more than 20 years
had lower energy and general well-being scores. Petter-
son et al found that patients with longer diabetes dura-
tion were generally more depressed and lacking in energy,
positive well-being, and general well-being [15]. We could
not find a significant association between the duration of
diabetes and well-being scores probably due to low num-
ber of patients in our study.
Diabetic complications affect the quality of life in
patients with diabetes leading to development of psycho-
logical disorders [11]. Akinci et al reported that patients
with no complications reported significantly better over-
all health-related quality of life [30]. In a meta-analysis by
De Groot, a significant association was found between
depression and complications of diabetes [31]. Higher
levels of depression were associated with increasing num-
bers of complications. Savli et al showed significant dif-
ferences in well-being between patients with and without
diabetic complications [11]. We found in our study that
there was a significant association between well-being
(except for anxiety) and diabetic complications. It was the
expected situation that diabetic patients with complica-
tions had lower level for the well-being. The lack of sig-
nificant association between diabetic complications and
anxiety may be due to the unawareness or indifference of
the diabetic patient.
Treatment Satisfaction
In Diabetes and Territory Survey project, men were in
general more satisfied than women about their treatment
[32]. However, we could not find a significant association
between gender and treatment satisfaction. We found a
Table 6: The Correlation Between Subscale Scores of WBQ-22 and DTSQ-2 and DTSQ-3 Scores (n = 105)
WBQ-22 subscales DTSQ-2 DTSQ-3
Correlation coefficient p Correlation coefficient p
Depression -0.296 0.002 -0.210 0.029
Anxiety -0.215 0.025 -0.145 0.134
Positive well-being -0.270 0.005 -0.134 0.167
Energy -0.213 0.027 -0.202 0.036
General well-being -0.278 0.004 -0.209 0.030Saatci et al. Health and Quality of Life Outcomes 2010, 8:67
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significant association between educational status and
treatment satisfaction. Patients with better educational
status had higher levels of treatment satisfaction.
Better results were achieved in patients treated with the
oral hypoglycemic agents (OHA) mono-therapy if com-
pared to those treated with insulin or combination ther-
apy [32]. On the other hand, insulin was associated with
greater improvements in treatment satisfaction [25]. We
could not find a significant association between the type
of treatment and treatment satisfaction probably due to
the low number of patients using insulin. It was interest-
ing that hypoglycemia and hyperglycemia perceptions
were not significantly related to the type of treatment.
Finally, there was an inverse correlation between treat-
ment satisfaction and HbA1c levels, indicating that the
questionnaire could be informative to some extent
regarding glyco-metabolic parameters [32]. We found a
significant association between glycemic control and
treatment satisfaction and between diabetic complica-
tions and treatment satisfaction.
Petterson et al found that the diabetes treatment satis-
faction score correlated with general well-being [5,15].
The DTSQ treatment satisfaction score correlated most
strongly with the general well-being score and least with
the negative well-being subscale score [5]. We also found
a significant correlation between treatment satisfaction
and well-being in our patients.
Riazi et al reported that the item on the DTSQ measur-
ing perceived frequency of hypoglycaemia correlated
most strongly with negative well-being and least with
positive well-being whereas the item measuring per-
ceived frequency of hyperglycaemia correlated most with
energy and least with positive well-being [5]. We found a
significant correlation between DTSQ-3 score (hypogly-
caemia) and WBQ-22 subscales of depression, energy
and general well-being.
Diabetes is perceived to be significantly more difficult
to manage than other common chronic conditions [33].
Inadequate patient skills, knowledge, and motivation
about self-care, and physicians practice behaviors and
settings are important determinants of adverse health
outcomes [22]. Individualized care of patients with diabe-
tes should consider both improving the quality of life and
controlling risk for severe complications [34]. Further
research will help us better understand the complex pro-
cess-to-outcome relationships in diabetes care [2]. Psy-
chosocial support should be provided to the patients with
type 2 diabetes and psychopathological conditions
including depression and anxiety should be treated and
their negative effects on the metabolic control should be
lessened [11]. Patients should be supported for being
active participants in the management of their condition
and balancing the biomedical and psychosocial outcomes
[15].
Limitations
Our study has some limitations. First of all the results
were cross-sectional. We have low number of patients;
particularly the ones under insulin therapy and all data
were self-reported. Memory problems and misconcep-
tions could not be excluded. We did not assess the rela-
tionship between income, sleeping, smoking, self-
monitoring of blood glucose and well-being and treat-
ment satisfaction. We could not compare the manage-
ment of patients with diabetes in primary and tertiary
level which was our aim in the beginning of the study
planning. We could not assess the effect of diabetes
patient education on well-being and treatment satisfac-
tion as we did not have a formal patient education pro-
gram and educated staff.
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